Client News

Abivax Presents First Quarter 2025 Financial Results

DEBRA Research and Dermaliq Enter into a Strategic Collaboration to Advance Cutaneous Drug Delivery for Epidermolysis Bullosa

InflaRx Announces Outcome of Interim Analysis for Vilobelimab Phase 3 Trial in Pyoderma Gangrenosum

CARBIOS Signs its First Biorecycled PET Sales Contracts with Two Global Cosmetics Leaders

Formycon and Fresenius Kabi announce the commercial launch of FYB202/Otulfi™, an approved ustekinumab biosimilar in Canada

Heidelberg Pharma Announces First Patient Dosed in Phase I Study of Amanitin-based ADC Candidate HDP-102 for Non-Hodgkin Lymphoma

AFYREN achieves “Responsible Care® Confirmed Diagnosis” certification and publishes its second sustainability report

Secarna Pharmaceuticals to Present New Data and Clinical Strategy for Lead Antisense Oligonucleotide Program SECN-15 at ASCO 2025

InflaRx to Participate in Upcoming Investor Conferences

ARTCLINE Establishes Scientific Advisory Board with Leading Experts from Nephrology, Intensive Care and Transfusion Medicine